Q1 FY26 revenue falls 22.5% YoY; PAT slips to Rs 96.17 lakh
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.7 pts less than Nifty Microcap 250 and 5.8 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Choksi Asia reported Q1 FY26 revenue from operations of Rs 922.10 lakh, down about 22.5% from Rs 1,189.75 lakh in Q1 FY25. Total income fell to Rs 950.88 lakh from Rs 1,218.79 lakh. PAT declined to Rs 96.17 lakh from Rs 107.43 lakh, with EPS of Rs 1.69 versus Rs 1.88. The company operates in the Non-Destructive Testing industry. Results were approved by the board on August 11, 2026 and the statutory auditors issued a clean limited review report with no qualifications.
Weak quarter with revenue falling over 22% YoY though profitability stayed positive. May weigh on near-term sentiment.